Status quo of hybrid coronary revascularization for multi-vessel coronary artery disease

Ralf E. Harskamp; Zhe Zheng; John H. Alexander; Judson B. Williams; Ying Xian; Michael E. Halkos; J. Matthew Brennan; Robbert J. de Winter; Peter K. Smith; Renato D. Lopes

doi:10.1016/j.athoracsur.2013.07.093

Status quo of hybrid coronary revascularization for multi-vessel coronary artery disease

Ralf E. Harskamp
, Zhe Zheng
, John H. Alexander
, Judson B. Williams
, Ying Xian
, Michael E. Halkos
, J. Matthew Brennan
, Robbert J. de Winter
, Peter K. Smith
, Renato D. Lopes

Research output: Contribution to journal › Review article › Academic › peer-review

Abstract

Hybrid coronary revascularization (HCR) combines bypass grafting of the left anterior descending (LAD) coronary artery with percutaneous coronary intervention (PCI) of non-LAD vessels. HCR has been performed as an alternative to CABG or multi-vessel PCI in thousands of patients since the late 1990s. In this review article, we provide an overview on patient selection, procedural sequence and timing, use of surgical techniques and anti-platelet agents. Additionally, patient recovery, satisfaction, costs and clinical outcomes of individual studies after HCR are evaluated. Future directions are also discussed, including the need for adequately powered randomized trials

Original language	English
Pages (from-to)	2268-2277
Journal	Annals of thoracic surgery
Volume	96
Issue number	6
DOIs	https://doi.org/10.1016/j.athoracsur.2013.07.093
Publication status	Published - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.athoracsur.2013.07.093

Cite this

@article{7582d1e0361b48fabcea69df91f6de6a,

title = "Status quo of hybrid coronary revascularization for multi-vessel coronary artery disease",

abstract = "Hybrid coronary revascularization (HCR) combines bypass grafting of the left anterior descending (LAD) coronary artery with percutaneous coronary intervention (PCI) of non-LAD vessels. HCR has been performed as an alternative to CABG or multi-vessel PCI in thousands of patients since the late 1990s. In this review article, we provide an overview on patient selection, procedural sequence and timing, use of surgical techniques and anti-platelet agents. Additionally, patient recovery, satisfaction, costs and clinical outcomes of individual studies after HCR are evaluated. Future directions are also discussed, including the need for adequately powered randomized trials",

author = "Harskamp, \{Ralf E.\} and Zhe Zheng and Alexander, \{John H.\} and Williams, \{Judson B.\} and Ying Xian and Halkos, \{Michael E.\} and Brennan, \{J. Matthew\} and \{de Winter\}, \{Robbert J.\} and Smith, \{Peter K.\} and Lopes, \{Renato D.\}",

year = "2013",

doi = "10.1016/j.athoracsur.2013.07.093",

language = "English",

volume = "96",

pages = "2268--2277",

journal = "Annals of thoracic surgery",

issn = "0003-4975",

publisher = "Elsevier USA",

number = "6",

}

TY - JOUR

T1 - Status quo of hybrid coronary revascularization for multi-vessel coronary artery disease

AU - Harskamp, Ralf E.

AU - Zheng, Zhe

AU - Alexander, John H.

AU - Williams, Judson B.

AU - Xian, Ying

AU - Halkos, Michael E.

AU - Brennan, J. Matthew

AU - de Winter, Robbert J.

AU - Smith, Peter K.

AU - Lopes, Renato D.

PY - 2013

Y1 - 2013

N2 - Hybrid coronary revascularization (HCR) combines bypass grafting of the left anterior descending (LAD) coronary artery with percutaneous coronary intervention (PCI) of non-LAD vessels. HCR has been performed as an alternative to CABG or multi-vessel PCI in thousands of patients since the late 1990s. In this review article, we provide an overview on patient selection, procedural sequence and timing, use of surgical techniques and anti-platelet agents. Additionally, patient recovery, satisfaction, costs and clinical outcomes of individual studies after HCR are evaluated. Future directions are also discussed, including the need for adequately powered randomized trials

AB - Hybrid coronary revascularization (HCR) combines bypass grafting of the left anterior descending (LAD) coronary artery with percutaneous coronary intervention (PCI) of non-LAD vessels. HCR has been performed as an alternative to CABG or multi-vessel PCI in thousands of patients since the late 1990s. In this review article, we provide an overview on patient selection, procedural sequence and timing, use of surgical techniques and anti-platelet agents. Additionally, patient recovery, satisfaction, costs and clinical outcomes of individual studies after HCR are evaluated. Future directions are also discussed, including the need for adequately powered randomized trials

U2 - 10.1016/j.athoracsur.2013.07.093

DO - 10.1016/j.athoracsur.2013.07.093

M3 - Review article

C2 - 24446561

SN - 0003-4975

VL - 96

SP - 2268

EP - 2277

JO - Annals of thoracic surgery

JF - Annals of thoracic surgery

IS - 6

ER -

Status quo of hybrid coronary revascularization for multi-vessel coronary artery disease

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this